California Public Employees Retirement System’s Beam Therapeutics BEAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-100,526
Closed -$3.21M – 1190
2023
Q2
$3.21M Hold
100,526
– – ﹤0.01% 1146
2023
Q1
$3.08M Sell
100,526
-19,874
-17% -$784K ﹤0.01% 1161
2022
Q4
$4.71M Sell
120,400
-9,488
-7% -$425K ﹤0.01% 1114
2022
Q3
$6.19M Buy
129,888
+41,331
+47% +$2.36M 0.01% 1055
2022
Q2
$3.43M Sell
88,557
-10,003
-10% -$398K ﹤0.01% 1130
2022
Q1
$5.65M Sell
98,560
-206
-0.2% -$13.5K ﹤0.01% 1110
2021
Q4
$7.87M Sell
98,766
-12,433
-11% -$1.06M 0.01% 1073
2021
Q3
$9.68M Buy
111,199
+5,813
+6% +$584K 0.01% 1018
2021
Q2
$13.6M Buy
105,386
+2,163
+2% +$172K 0.01% 867
2021
Q1
$8.26M Buy
103,223
+11,241
+12% +$1.07M 0.01% 1180
2020
Q4
$7.51M Buy
91,982
+11,966
+15% +$588K 0.01% 1189
2020
Q3
$1.97M Buy
80,016
+52,867
+195% +$1.31M ﹤0.01% 1841
2020
Q2
$760K Buy
+27,149
New +$585K ﹤0.01% 2406

Other funds holding BEAM

California Public Employees Retirement System's BEAM Position: Q3 2023 in Review

California Public Employees Retirement System sold out of Beam Therapeutics (BEAM) in Q3 2023, closing a stake of 100,526 shares — an estimated $3.21M sold.

California Public Employees Retirement System first reported a position in BEAM in Q2 2020 and held it in 13 quarters. The position peaked at $13.6M in Q2 2021. 194 funds tracked by Wall St. Rank hold BEAM as of Q3 2023.

  • California Public Employees Retirement System reported no remaining Beam Therapeutics position as of Q3 2023 after selling out during the quarter.
  • California Public Employees Retirement System sold 100,526 Beam Therapeutics shares in Q3 2023, an estimated $3.21M.
  • California Public Employees Retirement System first reported a position in Beam Therapeutics in Q2 2020 and held it in 13 quarters.
  • California Public Employees Retirement System's Beam Therapeutics position peaked at $13.6M in Q2 2021.
  • 194 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2023.

Based on California Public Employees Retirement System's 13F filing for Q3 2023, filed 2 Nov 2023.